262 related articles for article (PubMed ID: 23667256)
1. Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development.
Vannier C; Mock K; Brabletz T; Driever W
J Biol Chem; 2013 Jun; 288(26):18643-59. PubMed ID: 23667256
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
3. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
[TBL] [Abstract][Full Text] [Related]
4. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
[TBL] [Abstract][Full Text] [Related]
5. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.
Burk U; Schubert J; Wellner U; Schmalhofer O; Vincan E; Spaderna S; Brabletz T
EMBO Rep; 2008 Jun; 9(6):582-9. PubMed ID: 18483486
[TBL] [Abstract][Full Text] [Related]
6. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.
Sánchez-Tilló E; Lázaro A; Torrent R; Cuatrecasas M; Vaquero EC; Castells A; Engel P; Postigo A
Oncogene; 2010 Jun; 29(24):3490-500. PubMed ID: 20418909
[TBL] [Abstract][Full Text] [Related]
7. The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5.
Sundararajan V; Gengenbacher N; Stemmler MP; Kleemann JA; Brabletz T; Brabletz S
Oncotarget; 2015 Sep; 6(29):27083-96. PubMed ID: 26334100
[TBL] [Abstract][Full Text] [Related]
8. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma.
Wels C; Joshi S; Koefinger P; Bergler H; Schaider H
J Invest Dermatol; 2011 Sep; 131(9):1877-85. PubMed ID: 21593765
[TBL] [Abstract][Full Text] [Related]
10. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
[TBL] [Abstract][Full Text] [Related]
11. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation.
Ono H; Imoto I; Kozaki K; Tsuda H; Matsui T; Kurasawa Y; Muramatsu T; Sugihara K; Inazawa J
Oncogene; 2012 Nov; 31(47):4923-34. PubMed ID: 22286765
[TBL] [Abstract][Full Text] [Related]
12. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
13. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
14. Transient but not stable ZEB1 knockdown dramatically inhibits growth of malignant pleural mesothelioma cells.
Horio M; Sato M; Takeyama Y; Elshazley M; Yamashita R; Hase T; Yoshida K; Usami N; Yokoi K; Sekido Y; Kondo M; Toyokuni S; Gazdar AF; Minna JD; Hasegawa Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3(Suppl 3):S634-45. PubMed ID: 22086445
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.
Aigner K; Dampier B; Descovich L; Mikula M; Sultan A; Schreiber M; Mikulits W; Brabletz T; Strand D; Obrist P; Sommergruber W; Schweifer N; Wernitznig A; Beug H; Foisner R; Eger A
Oncogene; 2007 Oct; 26(49):6979-88. PubMed ID: 17486063
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT.
Al-Khalaf HH; Aboussekhra A
J Biol Chem; 2014 Nov; 289(45):31433-47. PubMed ID: 25261470
[TBL] [Abstract][Full Text] [Related]
17. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
[TBL] [Abstract][Full Text] [Related]
18. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
[TBL] [Abstract][Full Text] [Related]
19. SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
Hou L; Li Q; Yu Y; Li M; Zhang D
Mol Med Rep; 2016 Feb; 13(2):1681-8. PubMed ID: 26717907
[TBL] [Abstract][Full Text] [Related]
20. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]